- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
TCU’s Cannon Diagnosed with Non-Hodgkin’s Lymphoma
According to multiple reports, former TCU offensive tackle Marcus Gannon will begin chemotherapy at a Fort Worth hospital on Thursday for a form of non-Hodgkin’s lymphoma. Cannon, of course, had been deemed a potential first or second round pick in the upcoming 2011 NFL Draft, and was considered to be one of the premiere talents available at his position.
While murmurs that all was not well with Cannon’s health had been circulating amongst teams, it’s difficult to say how many really knew that he was dealing with this particular condition. Either way, it’s all but guaranteed at this point that the TCU product will drop in the draft -- the question now being how much.
Apparently, the tumor was first detected in Cannon’s abdomen in 2006. However, testing on it showed that it was benign. Later, in 2008, further testing on it still returned negative.
Finally, after the mass grew during the NFL Scouting Combine in February, rumors began to circulate that Cannon was battling testicular cancer. Ultimately, that rumor was proven to be incorrect.
In an effort to keep teams fully apprised of the situation, each NFL team was sent full biopsy results to prove that Cannon was not suffering from testicular cancer. The tests, however, did show that he was suffering from the aforementioned non-Hodgkin’s lymphoma.
Cannon’s four treatments are set to conclude on June 29.